Product
Sulfur Hexafluoride
Aliases
Lumason, SF6 Lipid Microspheres, SonoVue, Sulfur Hexafluoride Lipid Microspheres (1 other aliases)
Name
LumaSon
INN Name
SULFUR HEXAFLUORIDE
FDA Approved
Yes
6 clinical trials
1 organization
9 indications
1 document
Indication
Breast CancerIndication
Renal Cell CarcinomaIndication
Liver CancerIndication
Neonatal Hypoxic Ischemic EncephalopathyIndication
Neonatal StrokeIndication
Neonatal EncephalopathyIndication
UnspecifiedIndication
Liver DiseaseIndication
Premature BirthClinical trial
Characterizing Breast Masses Using an Integrative Framework of Machine Learning and RadiomicsStatus: Recruiting, Estimated PCD: 2024-11-05
Clinical trial
Multi-Modality Detection of RCC Recurrence Post AblationStatus: Recruiting, Estimated PCD: 2027-08-31
Clinical trial
2D and 3D Contrast Enhanced Ultrasound of ChemoembolizationStatus: Not yet recruiting, Estimated PCD: 2027-07-01
Clinical trial
Contrast Enhanced Ultrasound and Elastography of the Neonatal BrainStatus: Not yet recruiting, Estimated PCD: 2029-07-01
Clinical trial
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic LesionsStatus: Completed, Estimated PCD: 2023-08-09
Clinical trial
Contrast Enhanced Ultrasound and Elastography of the Preterm BrainStatus: Not yet recruiting, Estimated PCD: 2029-07-01
Document
DailyMed Label: LumaSonOrganization
Bracco Diagnostics Inc